Get notified when TENX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTenax Therapeutics holds routine annual meeting, elects seven directors for one-year terms
Filed June 4, 2026 · Period ending June 2, 2026 · ~1 min read
Key Changes
-
low
Shareholders elected seven directors to one-year terms expiring in 2027: June Almenoff, Michael Davidson, Declan Doogan, Christopher Giordano, Robyn Hunter, Gerald Proehl, and Stuart Rich.
Item 5.07 verify on EDGAR → -
low
Cherry Bekaert LLP ratified as independent auditor for 2026 with overwhelming shareholder support (21.3 million votes for, 3,688 against).
Item 5.07 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ISNR 10-Q) is open in full — no account needed.
Partner
Trade TENX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 5, 2026 · How we verify